Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuzhou Contay Biotechnology is a specialized biotechnology company focused on the development and large-scale manufacture of high-value nutritional and pharmaceutical ingredients. Utilizing advanced microbial fermentation and biocatalysis technologies, the company produces key compounds such as Pyrroloquinoline Quinone (PQQ), Vitamin K2 (MK-7), and S-Adenosyl-L-methionine (SAMe). Contay Biotech serves the global dietary supplement, functional food, and pharmaceutical industries, emphasizing green chemistry and sustainable production methods. Their facilities are designed to meet international quality standards, including GMP certifications, to support their export-oriented business model. The company is recognized as a leading global supplier of PQQ and other fermentation-derived bio-actives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuzhou Contay Biotechnology.